Reports

Increase in awareness and rise in acceptance are driving the global transcranial magnetic stimulators market. Surge in incidence of neurological and psychiatric disorders such as depression, anxiety, Parkinson's disease, and chronic pain has spurred the need for safe and efficient treatment methods. Ongoing research and trials exploring transcranial magnetic stimulator (TMS) applications in broader disorders beyond its traditional scope are propelling market expansion. Furthermore, introduction of advanced technologies in TMS to address neurological disorders is expected to bolster the global transcranial magnetic stimulators industry size during the forecast period.
Expansion of applications of transcranial magnetic stimulators market offer lucrative opportunities to market players. Companies are focusing on introducing TMS systems with enhanced precision, personalized treatment algorithms, and innovative simulation techniques in order to increase market share.
Transcranial magnetic stimulators are devices that utilize non-invasive magnetic pulses to stimulate specific brain regions, primarily for therapeutic purposes in neurological and psychiatric disorders.
These tools create electrical currents in the brain, adjusting neural activity to potentially alleviate conditions such as depression, anxiety, and chronic pain. Recent innovations in transcranial magnetic stimulation (TMS) technology involve inventive coil designs, precise systems for targeted therapy, and upgraded software for accurate customization.
These enhancements enable deeper brain stimulation, enhance treatment effectiveness, and allow for real-time adjustments during therapy sessions. Additionally, incorporation of advanced navigation systems and neuroimaging techniques results in more exact and personalized applications of TMS.
Increase in awareness about TMS among both medical practitioners and patients is enhancing its reputation as a safe and non-invasive therapy. TMS has attracted attention for its ability to regulate brain activity using magnetic pulses, showing promise in alleviating symptoms associated with a range of neurological disorders such as depression, anxiety, Parkinson's disease, and chronic pain.
Rise in scientific evidence supporting the effectiveness of TMS across various neurological conditions is enhancing its acceptance among patients seeking alternative treatments and healthcare professionals exploring non-pharmaceutical therapies.
Surge in clinical research is reinforcing the robust clinical evidence supporting the effectiveness of TMS, fostering confidence among healthcare professionals and expanding its integration into treatment protocols. This validation is making TMS a more widely accepted therapeutic choice.
TMS is no longer confined to depression; ongoing studies exploring its potential for conditions such as addiction, migraines, and stroke are broadening its applicability to diverse patient groups, thus extending its impact and market potential.
For instance, in 2026, a systematic review and network meta-analysis of 141 randomized controlled trials involving 10,587 patients evaluated different repetitive transcranial magnetic stimulation (rTMS) approaches for major depressive disorder (MDD). The study found that multiple rTMS modalities, including theta burst stimulation (TBS), accelerated TMS, deep TMS, and conventional high-frequency protocols, demonstrated significantly better response outcomes compared with sham stimulation. Theta burst stimulation showed the highest probability of efficacy, particularly among patients with treatment-resistant depression, supporting the continued evolution of faster and more targeted TMS treatment protocols.
Cutting-edge advancements are revolutionizing transcranial magnetic stimulation (TMS), elevating its accuracy, effectiveness, and versatility in treating diverse neurological conditions. These breakthroughs involve sophisticated TMS systems equipped with more precise targeting capabilities, personalized treatment algorithms, and innovative stimulation patterns.
Advancements in coil designs, navigational tools, and neuroimaging techniques enable a tailored and responsive application of TMS therapy, maximizing its therapeutic capabilities. This technological progression signifies substantial strides in the realm of transcranial magnetic stimulation (TMS), ushering in novel treatment opportunities and fostering market expansion.
For instance, In September 2025, BrainsWay received U.S. FDA clearance for an accelerated Deep TMS treatment protocol for major depressive disorder (MDD), expanding the clinical utility of its Deep TMS platform. The new protocol, based on a multicenter randomized controlled study, uses intermittent theta burst stimulation (iTBS) and reduces the acute treatment phase from approximately four weeks to six treatment days while achieving comparable clinical outcomes to standard Deep TMS protocols. This advancement is expected to support broader adoption of Deep TMS by improving treatment accessibility, reducing patient visits, and increasing clinic throughput.
Recent innovations are expanding the potential applications of TMS beyond established psychiatric indications. In 2025, Magstim received FDA clearance for its Magstim Rapid magnetic stimulation technology for chronic pain management, expanding the role of non-invasive magnetic stimulation into pain-care applications. In parallel, advanced TMS approaches such as theta burst stimulation (TBS), deep TMS, and personalized targeting techniques continue to be evaluated for neurological applications, including stroke rehabilitation, highlighting the broader therapeutic potential of next-generation neuromodulation platforms.
By integrating these advanced technologies, TMS not only enhances treatment efficacy, but also expands its potential in addressing a broader spectrum of neurological disorders, thereby propelling the transcranial magnetic stimulators market growth.
In terms of product type, the deep TMS segment dominated the global transcranial magnetic stimulators market in 2025. This can be ascribed to its innovative methodology and effectiveness in treating a broad range of neurological conditions.
This technique involves a specialized coil design within a padded helmet, enabling precise stimulation of deeper brain regions that were previously hard to reach using traditional TMS approaches. This innovation has attracted attention for its potential in addressing psychiatric and neurological disorders, including major depressive disorder, obsessive-compulsive disorder, and addiction.
The capability to target these deeper brain areas broadens the scope of treatable conditions, while the increasing clinical evidence supporting its efficacy contributes to its adoption. Leading companies such as BrainsWay are pioneering these cutting-edge solutions. These factors are projected to drive the global transcranial magnetic stimulators market demand in the near future.
Based on application, the therapeutic segment accounted for the largest global transcranial magnetic stimulators market share in 2025. This is ascribed to its broad range of applications in managing diverse neurological and psychological disorders.
TMS has proven effective in addressing conditions such as depression, anxiety, obsessive-compulsive disorder (OCD), Parkinson's disease, and chronic pain. Its non-invasive methodology, employing magnetic pulses to modulate brain activity, offers a compelling alternative to traditional treatments.
Robust clinical research supporting TMS efficacy across various conditions, as highlighted by the National Institutes of Health (NIH) citing response rates of 30% to 50% in depression treatment compared to 20% to 40% with medications alone, contributes to the growing acceptance and adoption of TMS in therapeutic settings. This expanding body of evidence underscores TMS's viability and significantly influences market perceptions and uptake.
As per transcranial magnetic stimulators market analysis, North America dominated the global industry in 2025. This is ascribed to well-established healthcare system and robust insurance coverage for TMS therapy.
However, North America grapples with high incidence of neurological and psychiatric disorders such as depression, anxiety, and chronic pain, creating a larger potential market for TMS therapy and consequently driving its adoption and market growth.
According to statistics from the National Institute of Mental Health, over 21 million adults in the U.S. experience at least one major depressive episode annually. The country has a history of pioneering medical technology adoption, including TMS, which stemmed from early research and clinical trials.
Initiatives such as the U.S. National Institutes of Health BRAIN Initiative and FDA regulations provide crucial infrastructure and research funding, fostering confidence and expediting innovation within the region.
Countries in Europe are promoting awareness about TMS therapy, which is resulting in rise in patient demand and acceptance of this treatment. Moreover, efforts to expand insurance coverage and encourage the integration of TMS into clinical practice have made it more accessible throughout the continent.
Supportive healthcare policies, increase in awareness among healthcare professionals and patients, as well as favorable reimbursement policies in select countries in Europe, have facilitated the widespread adoption of TMS in the region.
The increasing burden of treatment-resistant depression is driving wider adoption of transcranial magnetic stimulation (TMS) across Europe. Recent guideline updates, including the 2024 Dutch multidisciplinary depression guideline, reaffirmed the effectiveness of rTMS for patients with treatment-resistant depression, particularly high-frequency left-sided and bilateral stimulation protocols. These developments are supporting greater integration of TMS into clinical practice and improving acceptance of neuromodulation therapies as an alternative to traditional pharmacological approaches.
As per transcranial magnetic stimulators market research, Asia Pacific, with its substantial population, particularly in countries such as China and India, presents significant market potential for TMS therapy.
According to the World Health Organization, more than 60 million people in Asia Pacific are affected by depression, emphasizing the pressing need for effective treatments such as TMS. Additionally, prevalent neurological conditions such as Parkinson's disease and chronic pain contribute to the potential applications of TMS in this region.
Economic development in Asia Pacific is leading to increased healthcare spending, fostering the adoption of advanced medical technologies such as TMS and facilitating the expansion of the market in the region.
The global transcranial magnetic stimulators market is fragmented, with the presence of large number of players. Manufacturers are adopting strategies such as investment in R&D and merger & acquisition to increase market share.
Neurosoft, Magstim, Nexstim plc, MagVenture, Inc., BrainsWay, Seber Medical, and Soterix Medical, Inc. are the prominent players in the market.
Leading players in the transcranial magnetic stimulators market report have been profiled based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and latest developments.
| Attribute | Detail |
|---|---|
| Size in 2025 | US$ 298.7 Mn |
| Forecast (Value) in 2036 | More than US$ 721.4 Mn |
| Growth Rate (CAGR) | 8.2% |
| Forecast Period | 2026-2036 |
| Historical Data Available for | 2021-2025 |
| Quantitative Units | US$ Mn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation | Product Type
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 298.7 Mn in 2025
It is projected to reach more than US$ 721.4 Mn by 2036
It is anticipated to be 8.2% from 2026 to 2036
North America is expected to account for the largest share from 2026 to 2036
Neurosoft, Magstim, Nexstim plc, MagVenture, Inc., BrainsWay, Seber Medical, and Soterix Medical, Inc. among others.
Table 01: Global Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Product Type, 2021 to 2036
Table 02: Global Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Application, 2021 to 2036
Table 03: Global Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by End-user, 2021 to 2036
Table 04: Global Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Region, 2021 to 2036
Table 05: North America Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Product Type, 2021 to 2036
Table 06: North America Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Application, 2021 to 2036
Table 07: North America Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by End-user, 2021 to 2036
Table 08: North America Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Country, 2021 to 2036
Table 09: Europe Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Product Type, 2021 to 2036
Table 10: Europe Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Application, 2021 to 2036
Table 11: Europe Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by End-user, 2021 to 2036
Table 12: Europe Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Country/Sub-region, 2021 to 2036
Table 13: Asia Pacific Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Product Type, 2021 to 2036
Table 14: Asia Pacific Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Application, 2021 to 2036
Table 15: Asia Pacific Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by End-user, 2021 to 2036
Table 16: Asia Pacific Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Country/Sub-region, 2021 to 2036
Table 17: Latin America Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Product Type, 2021 to 2036
Table 18: Latin America Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Application, 2021 to 2036
Table 19: Latin America Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by End-user, 2021 to 2036
Table 20: Latin America Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Country/Sub-region, 2021 to 2036
Table 21: Middle East & Africa Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Product Type, 2021 to 2036
Table 22: Middle East & Africa Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Application, 2021 to 2036
Table 23: Middle East & Africa Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by End-user, 2021 to 2036
Table 24: Middle East & Africa Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, by Country/Sub-region, 2021 to 2036
Figure 01: Global Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, 2021 to 2036
Figure 02: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 03: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Repetitive TMS, 2025 and 2036
Figure 04: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Deep TMS, 2025 and 2036
Figure 05: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Others, 2025 and 2036
Figure 06: Global Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 07: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Application 2025 and 2036
Figure 08: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Therapeutics, 2025 and 2036
Figure 09: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Diagnostics, 2025 and 2036
Figure 10: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Research, 2025 and 2036
Figure 11: Global Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 12: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by End-user, 2025 and 2036
Figure 13: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Hospitals, 2025 and 2036
Figure 14: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Specialty Centers, 2025 and 2036
Figure 15: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Others, 2025 and 2036
Figure 16: Global Transcranial Magnetic Stimulators Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 17: Global Transcranial Magnetic Stimulators Market Value Share Analysis, by Region, 2025 and 2036
Figure 18: Global Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Region, 2026 to 2036
Figure 19: North America Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, 2021 to 2036
Figure 20: North America Transcranial Magnetic Stimulators Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 21: North America Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 22: North America Transcranial Magnetic Stimulators Market Value Share Analysis, by Application, 2025 and 2036
Figure 23: North America Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 24: North America Transcranial Magnetic Stimulators Market Value Share Analysis, by End-user, 2025 and 2036
Figure 25: North America Transcranial Magnetic Stimulators Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 26: North America Transcranial Magnetic Stimulators Market Value Share Analysis, by Country, 2025 and 2036
Figure 27: North America Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Country, 2026 to 2036
Figure 28: Europe Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, 2021 to 2036
Figure 29: Europe Transcranial Magnetic Stimulators Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 30: Europe Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 31: Europe Transcranial Magnetic Stimulators Market Value Share Analysis, by Application, 2025 and 2036
Figure 32: Europe Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 33: Europe Transcranial Magnetic Stimulators Market Value Share Analysis, by End-user, 2025 and 2036
Figure 34: Europe Transcranial Magnetic Stimulators Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 35: Europe Transcranial Magnetic Stimulators Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 36: Europe Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 37: Asia Pacific Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, 2021 to 2036
Figure 38: Asia Pacific Transcranial Magnetic Stimulators Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 39: Asia Pacific Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 40: Asia Pacific Transcranial Magnetic Stimulators Market Value Share Analysis, by Application 2025 and 2036
Figure 41: Asia Pacific Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 42: Asia Pacific Transcranial Magnetic Stimulators Market Value Share Analysis, by End-user, 2025 and 2036
Figure 43: Asia Pacific Transcranial Magnetic Stimulators Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 44: Asia Pacific Transcranial Magnetic Stimulators Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 45: Asia Pacific Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 46: Latin America Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, 2021 to 2036
Figure 47: Latin America Transcranial Magnetic Stimulators Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 48: Latin America Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 49: Latin America Transcranial Magnetic Stimulators Market Value Share Analysis, by Application, 2025 and 2036
Figure 50: Latin America Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 51: Latin America Transcranial Magnetic Stimulators Market Value Share Analysis, by End-user, 2025 and 2036
Figure 52: Latin America Transcranial Magnetic Stimulators Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 53: Latin America Transcranial Magnetic Stimulators Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 54: Latin America Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 55: Middle East & Africa Transcranial Magnetic Stimulators Market Value (US$ Mn) Forecast, 2021 to 2036
Figure 56: Middle East & Africa Transcranial Magnetic Stimulators Market Value Share Analysis, by Product Type, 2025 and 2036
Figure 57: Middle East & Africa Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Product Type, 2026 to 2036
Figure 58: Middle East & Africa Transcranial Magnetic Stimulators Market Value Share Analysis, by Application, 2025 and 2036
Figure 59: Middle East & Africa Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Application, 2026 to 2036
Figure 60: Middle East & Africa Transcranial Magnetic Stimulators Market Value Share Analysis, by End-user, 2025 and 2036
Figure 61: Middle East & Africa Transcranial Magnetic Stimulators Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 62: Middle East & Africa Transcranial Magnetic Stimulators Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 63: Middle East & Africa Transcranial Magnetic Stimulators Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 64: Global Transcranial Magnetic Stimulators Market Share Analysis, by Company, 2025